NYSE:DGXHealthcare
Quest Diagnostics (DGX) Lifts 2026 Outlook As Investors Ask If The Stock Is Fully Valued
Quest Diagnostics (DGX) stock has been in focus after the company reported second quarter and six month 2026 results and raised its full year revenue and earnings guidance, indicating that the company now expects higher financial performance.
See our latest analysis for Quest Diagnostics.
Quest Diagnostics shares have picked up pace over 2026, with a 1‑month share price return of 8.34%, a 90‑day gain of 23.58%, and a 1‑year total shareholder return of 37.26%. This reflects recent share price...